Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)Yuankai Shi, Lin Wang, Jianhua Chen et al.|Journal of Thoracic Oncology|2024Cited by 40
Method Development and Validation for Simultaneous Determination of Six Tyrosine Kinase Inhibitors and Two Active Metabolites in Human Plasma Using UPLC–MS/MS for Therapeutic Drug MonitoringMenghua Zhang, Liyan Miao, Xiaoxue Liu et al.|SSRN Electronic Journal|2021Cited by 0
Impact of administration route and gene polymorphisms on the serum concentration of voriconazole among Chinese patients with hematologic malignancies.Zhiyao Chen, Liyan Miao, Menghua Zhang et al.|PubMed|2025Cited by 0